1-3 of 3
Shuhui Deng
Close
Sort by
Journal Articles

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

Shuhui Deng, Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martin, Madhumouli Chatterjee, Giulia Giorgetti, Chandraditya Chakraborty, Poonam Kalhotra, Ting Du, Yao Yao, Rao H Prabhala, Masood A Shammas, Annamaria Gulla, Anil Aktas Samur, Mehmet K. Samur, Lugui Qiu, Kenneth C. Anderson, Mariateresa Fulciniti, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv bloodadvances.2023012298.
https://doi.org/10.1182/bloodadvances.2023012298
Published: 2024
Includes: Supplemental data
Journal Articles

Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH

Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Wenqiang Yan, Lanting Liu, Chenxing Du, Zhen Yu, Yan Xu, Mu Hao, Shuhui Deng, Weiwei Sui, Rui Lyu, Wei Liu, Qi Wang, Dehui Zou, Linping Hu, Jianxiang Wang, Yu-Tzu Tai, Kenneth C. Anderson, Lei Zhang, Tao Cheng, Anders Zetterberg, Nikhil C. Munshi, Lugui Qiu, Gang An
Journal: Blood Advances
Blood Adv (2022) 6 (2): 441–451.
https://doi.org/10.1182/bloodadvances.2021004992
Published: 2022
Includes: Supplemental data
Journal Articles

The impact of response kinetics for multiple myeloma in the era of novel agents

Clinical Trials & Observations
Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du, Zengjun Li, Shuhua Yi, Yan Xu, Rui Lv, Wei Liu, Shuhui Deng, Weiwei Sui, Qi Wang, Dehui Zou, Jianxiang Wang, Tao Cheng, Fenghuang Zhan, Yu-Tzu Tai, Chenglu Yuan, Xin Du, Lugui Qiu, Kenneth C. Anderson, Gang An
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2895–2904.
https://doi.org/10.1182/bloodadvances.2019000432
Published: 2019
Includes: Supplemental data